Catheter Precision (VTAK)
VIVO cardiac-mapping devices and FLYTE private aviation services.
Flyte Secures International Approval to Launch Private Aviation Service Across The Bahamas and Caribbean
Landmark international milestone unlocks significant new markets and broadens Flyte's addressable aviation footprint beyond the United States New capabilities connect Flyte's growing Florida network with high-demand leisure and resort destinations throughout The Bahamas and Caribbean
Flyte Surpasses 10,000 Consumer Accounts as WebApp Growth Accelerates
New Account Creation Increased 170% During the First 17 Days of August Compared to the Same Period in July Flyte Has Added More Accounts Since July 1 Than During the Entire First Half of 2026 Growing First-Party Customer Base Now Spans 174 Airports Across 19 States FORT MILL, S.C., Aug. 20, 2026 (GLOBE NEWSWIRE) -- Flyte, a subsidiary of Catheter Precision, Inc. (NYSE American: VTAK) (“VTAK” or the “Company”), today announced that more than 10,000 consumer accounts are now registered on the Flyte WebApp, marking a significant milestone as new account creation continues to accelerate across the Company's technology-enabled private aviation platform.
Flyte Achieves Record Revenues in July
July 2026 Revenue Increased 102% sequential July Over June to Approximately $640,000 Retail Platform, Strategic Partnerships and Influencer Marketing Fuel Accelerating Growth FORT MILL, S.C., Aug. 06, 2026 (GLOBE NEWSWIRE) -- Flyte, a subsidiary of Catheter Precision, Inc. (NYSE American: VTAK) (“VTAK”), today announced record monthly revenue for July 2026, marking the strongest operating month in Flyte's history as demand continues to accelerate across its private aviation platform.
Aviation Stocks Lift Off: Flyte (VTAK) Teams Up with Blade Urban Air Mobility
Delta, British Columbia--(Newsfile Corp. - July 22, 2026) - Investorideas.com, a trusted leader in publishing investing ideas for over 25
FLYTE EXPANDS STRATEGIC RELATIONSHIP WITH VOLATO BY JOINING VAUNT PLATFORM
Flyte Gains Access to Fast-Growing Private Aviation Membership Network While Unlocking New Revenue Opportunities across Its Cirrus Vision Jet Fleet Creates Additional Distribution Channel for Flyte and Enhances Empty Leg Inventory Available to Vaunt Members FORT MILL, S.C., June 11, 2026 (GLOBE NEWSWIRE) -- Fly Flyte, Inc. ("Flyte"), the rapidly growing Regional Air Mobility subsidiary of Catheter Precision, Inc. (NYSE American: VTAK), today announced that it has joined the Vaunt operator network, a membership-based private aviation platform owned by Volato Group, Inc. (NYSE American: SOAR).
Flyte (VTAK) Makes Strategic Investment in Volato (SOAR)
VTAK Becomes Volato's Largest Shareholder through Acquisition of a 7.5% Ownership Stake Investment Supports Potential Collaboration across Aviation Platforms and Accelerates Growth Opportunities across Both Companies VTAK Becomes Volato's Largest Shareholder through Acquisition of a 7.5% Ownership Stake Investment Supports Potential Collaboration across Aviation Platforms and Accelerates Growth Opportunities across Both Companies
FLYTE ACTIVATES HIGH-FREQUENCY MEMORIAL DAY WEEKEND FLIGHT NETWORK TO CAPTURE SURGING NORTHEAST DEMAND
Company Deploys Scalable Short-Haul Model into Peak Travel Window as Millions Exit NYC Metro Flagship Routes to Nantucket, Hamptons, and Martha's Vineyard Positioned for Immediate Revenue Acceleration and High Utilization FORT MILL, S.C., May 21, 2026 (GLOBE NEWSWIRE) -- Flyte, a regional air mobility company focused on making private aviation more accessible and flexible for modern travelers, today announced the full-scale activation of its Memorial Day flight network, aggressively deploying aircraft across its Northeast corridor to capitalize on one of the largest and most predictable travel surges of the year.
FLYTE ACTIVATES HIGH-FREQUENCY PREAKNESS FLIGHT PROGRAM, DEPLOYING FLEET TO SERVE STRONG NORTHEAST DEMAND
Company Deploys Scalable Short-Haul Model Following Kentucky Derby to Monetize Peak Travel Window Flagship Routes from NYC, Boston, DC, and Philadelphia Positioned to Drive Immediate Revenue, High Utilization, and Dense Flight Activity NEW YORK, May 12, 2026 (GLOBE NEWSWIRE) -- Flyte, the regional air mobility subsidiary of Catheter Precision, Inc. (NYSE American: VTAK) (“VTAK” or the “Company”), today announced the positioning of aircraft across the Northeast to support increased travel demand this coming weekend in anticipation of the Preakness Stakes on Saturday, May 16th. The program centers on Baltimore/Washington International Airport (BWI), the primary access point for race attendees, with high-frequency short-haul service from major Northeast metros.
Flyte Increases Capacity and Launches Hiring Initiative as Spirit Airlines Shutdown Disrupts U.S. Air Travel
Premium Short-Haul Operator Continues Planned Vision Jet Fleet Expansion and Opens Hiring Pipeline for Impacted Pilots and Aviation Professionals Premium Short-Haul Operator Continues Planned Vision Jet Fleet Expansion and Opens Hiring Pipeline for Impacted Pilots and Aviation Professionals
Flyte Deploys Additional Vision Jets in the Northeast to Capture Surging Summer Demand
Positioned to Meet Accelerating Travel Activity across New York City, The Hamptons, Nantucket and Martha's Vineyard Scalable Short-Haul Luxury Aviation Platform Targeting Key Regional Travel Markets FORT MILL, S.C., April 28, 2026 (GLOBE NEWSWIRE) -- Flyte, the regional air mobility subsidiary of Catheter Precision, Inc. (NYSE American: VTAK) (“VTAK” or the “Company”), today announced the expansion of its Cirrus Vision Jet fleet ahead of peak summer demand, scaling short-haul service from New York City to East Hampton, Nantucket, Martha's Vineyard, Newport, and Cape Cod.
Short Interest in Catheter Precision, Inc. (NYSEAMERICAN:VTAK) Expands By 91.9%
Catheter Precision, Inc. (NYSEAMERICAN:VTAK - Get Free Report) saw a significant growth in short interest in April. As of April 15th, there was short interest totaling 80,782 shares, a growth of 91.9% from the March 31st total of 42,085 shares. Approximately 3.2% of the shares of the stock are sold short. Based on an average
New LockeT Data Accepted in Leading Electrophysiology Journal
FORT MILL, S.C., April 06, 2026 (GLOBE NEWSWIRE) -- Catheter Precision, Inc. (NYSE American: VTAK) (“VTAK” or the “Company”) today announced that the manuscript titled “Safety and Efficacy of LockeT Suture Retention Device for Large-Bore Venous Access Closure” has been accepted by the Journal of Interventional Cardiac Electrophysiology (JICE), a leading medical journal in the field of electrophysiology.
Catheter Precision Reports 2025 Results and Updates on Strategic Expansion
Clinical, Commercial and Regulatory Milestones Achieved in 2025 Establish a Strong Foundation in Life Sciences as Revenue Increases 95% Year Over Year
Catheter Precision (VTAK) to Release Earnings on Friday
Catheter Precision (NYSEAMERICAN:VTAK - Get Free Report) will likely be releasing its results before the market opens on Friday, March 27th. Analysts expect Catheter Precision to post earnings of ($20.90) per share and revenue of $1.70 million for the quarter. Catheter Precision Stock Performance VTAK stock opened at $1.31 on Friday. The stock has a
VTAK Announces Definitive Merger Agreement to Acquire 100% of Fly Flyte Inc.
Transaction Delivers Wholly Owned, Scalable Asset-Backed, Aviation Platform with Accelerating Revenue and Consolidated Control Positions VTAK at the Center of High-Growth Regional Air Mobility Ahead of Industry-Wide eVTOL Commercialization FORT MILL, S.C., March 10, 2026 (GLOBE NEWSWIRE) -- Catheter Precision, Inc. (NYSE American: VTAK) today announced that it has completed the acquisition of the remaining 80.02% equity interest in Fly Flyte, Inc. (“Flyte”) from Creatd, Inc. (OTCQB: CRTDD), resulting in 100% ownership of the AI-enabled regional aviation operator.
Catheter Precision's LockeT Suture Retention Device to be Featured in Live Cases at ISLAA 2026
FORT MILL, S.C., March 06, 2026 (GLOBE NEWSWIRE) -- Catheter Precision, Inc. (NYSE American: VTAK), a pioneer in medical technology for the cardiac electrophysiology market, today announced that its LockeT suture retention device will be highlighted during live procedural cases at the International Symposium of Left Atrial Appendage 2026 conference. The event, co-hosted by the Academy for Continued Healthcare Learning (ACHL) and ISLAA Foundation, will take place from March 5-6, 2026, at the Biltmore Hotel in Los Angeles, California.
Catheter Precision Divests Non-Core Assets As It Shifts Focus
Catheter Precision (NYSE: VTAK) shares are down on Thursday as the company announced a strategic divestiture of its non-core assets.
Catheter Precision Announces Strategic Sale of Non-Core Assets to Strengthen Balance Sheet and Accelerate Electrophysiology Growth
Upfront Cash, Equity Participation and Tiered Royalty Structure Providing Long-Term Revenue Upside Upfront Cash, Equity Participation and Tiered Royalty Structure Providing Long-Term Revenue Upside
VTAK Acquires 20% Interest in Creatd's Subsidiary Fly Flyte, Inc.
New York, NY, Feb. 17, 2026, – PRISM MediaWire (Press Release Service – Press Release Distribution) – Creatd, Inc. (OTCQB: CRTD) announced that Catheter Precision, Inc. (NYSE American: VTAK) has acquired a 20% equity interest in Fly Flyte, Inc., its subsidiary, through a secondary purchase from an existing shareholder.
VTAK Acquires 20% Interest in Creatd's Subsidiary Fly Flyte, Inc.
Strategic Partnership: Creatd expanded Fly Flyte's investor network by adding NYSE-listed VTAK as an investor in its subsidiary. Portfolio Expansion: Creatd continues advancing its portfolio strategy through multiple active acquisition discussions.